Titelia

Holdings of Spruce Street Capital LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
25 in 2 countries
Top ten
68.9 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Relmada Therapeutics Inc 6,262,11443M $
2LB Pharmaceuticals Inc 1,376,15933.6M $
3Dianthus Therapeutics Inc 373,27431.3M $
4Relay Therapeutics Inc 2,984,12529.7M $
5Alto Neuroscience Inc 1,325,21029.1M $
6Centessa Pharmaceuticals PLC 489,84919.5M $
7SAVARA INC 3,383,17518.5M $
8KalVista Pharmaceuticals Inc 897,68118.1M $
9VAXCYTE INC 245,70914.3M $
10Enliven Therapeutics Inc 329,00612.9M $
11Surrozen Inc 432,04012.6M $
12Enanta Pharmaceuticals Inc 932,59811.8M $
13Perspective Therapeutics Inc 2,627,10711M $
14Minerva Neurosciences Inc 1,655,50010M $
15Century Therapeutics Inc 4,059,0549.2M $
16ALUMIS INC 392,5748.6M $
17SAB Biotherapeutics Inc 2,198,5028.4M $
18Erasca Inc 422,5436.8M $
19Inhibikase Therapeutics Inc 3,581,6036M $
20Maze Therapeutics Inc 200,0006M $
21AN2 Therapeutics Inc 1,661,0735.6M $
22Lexeo Therapeutics Inc 928,5935.3M $
23Alector Inc 2,101,0684.5M $
24LeonaBio Inc 393,7013.8M $
25Corvus Pharmaceuticals Inc 231,5853.4M $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 94.6 %
  • United Kingdom 5.4 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States24343.5M $94.64 %
2United Kingdom119.5M $5.36 %
Cite this page

Titelia. "Holdings of Spruce Street Capital LP". https://titelia.com/en/funds/US13F2050194